Eris Lifesciences Limited (NSE:ERIS)
India · Delayed Price · Currency is INR 1,684.50
+9.70 (0.58%)
Aug 14, 2025, 3:30 PM IST
Eris Lifesciences Market Cap
Eris Lifesciences has a market cap or net worth of 229.44 billion as of August 15, 2025. Its market cap has increased by 49.78% in one year.
Market Cap
229.44B
Enterprise Value
256.34B
Revenue
29.35B
Ranking
n/a
PE Ratio
59.41
Stock Price
1,684.50
Market Cap Chart
Since June 29, 2017, Eris Lifesciences's market cap has increased from 82.71B to 229.44B, an increase of 177.42%. That is a compound annual growth rate of 13.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2025 | 229.44B | 22.69% |
| Dec 31, 2024 | 187.00B | 51.07% |
| Dec 29, 2023 | 123.79B | 40.63% |
| Dec 30, 2022 | 88.02B | -14.80% |
| Dec 31, 2021 | 103.31B | 31.20% |
| Dec 31, 2020 | 78.75B | 20.81% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 29, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 3,938.27B |
| Divi's Laboratories | 1,627.99B |
| Cipla | 1,263.32B |
| Apollo Hospitals Enterprise | 1,124.61B |
| Mankind Pharma | 1,020.51B |
| Zydus Lifesciences | 994.96B |
| Fortis Healthcare | 703.62B |
| Alkem Laboratories | 639.37B |